Nike Air Yeezy

Rares to IPO the World’s Most Expensive Sneaker at ComplexCon

Retrieved on: 
Tuesday, November 2, 2021

This set a new world record for the most expensive sneaker ever sold in a private sale .

Key Points: 
  • This set a new world record for the most expensive sneaker ever sold in a private sale .
  • View the full release here: https://www.businesswire.com/news/home/20211102005615/en/
    At ComplexCon, the yearly pop culture festival, Rares will feature the actual Yeezy shoe at a curated booth, along with other never-before-seen sneakers from its collection.
  • Attendees will have front row access to some of the worlds most coveted sneakers, with a few pairs available via IPO.
  • We initially acquired the Yeezy shoe because of its importance in shaping sneaker culture as we know it today, says Sapp.

Sneaker Investment App Rares Announces $4 Million Seed Funding Round, Led by MaC Venture Capital

Retrieved on: 
Tuesday, October 12, 2021

Rares , an innovative social investing platform and the first alternative asset marketplace exclusively for sneakers, announces today that it has raised $4 million in a seed funding round led by MaC Venture Capital.

Key Points: 
  • Rares , an innovative social investing platform and the first alternative asset marketplace exclusively for sneakers, announces today that it has raised $4 million in a seed funding round led by MaC Venture Capital.
  • Sneaker culture was born out of the Black community, but today many folks are priced out of the market, said Marlon Nichols, Co-Founder and Managing General Partner of MaC Venture Capital.
  • So as a minority, being able to close this significant SEED investment round with MaC Venture Capital leading provides my incredible team and I with a new inspired enthusiasm for the bright future ahead for Rares.
  • For more information please email Hanif Sumner, [email protected]
    MaC Venture Capital is a seed-stage venture capital firm that invests in technology startups leveraging shifts in cultural trends and behaviors.